Litcius/Paper detail

Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends

Nelly F Ly, Clare Flach, Thom S. Lysen, Emanuil Markov, Hanne van Ballegooijen, Peter Rijnbeek, Talita Duarte‐Salles, Carlen Reyes, Luis H. John, Leila Karimi, Christian Reich, Sam Salek, Deborah Layton

2023Drug Safety33 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMedical prescriptionEuropean unionReferralConfidence intervalEmergency medicineIncidence (geometry)PopulationPsychological interventionPharmacoepidemiologyCohortPediatricsIntensive care medicineInternal medicineEnvironmental healthFamily medicinePharmacologyPhysicsOpticsBusinessEconomic policyPsychiatryAntibiotic Use and ResistanceAntibiotics Pharmacokinetics and EfficacyPneumonia and Respiratory Infections
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends | Litcius